治療用抗体の世界市場（2023年版）：抗体タイプ別、由来別、用途別、地域別、国別の分析、市場考察、予測（2019年～2029年）

世界の治療用抗体の市場規模は、2022年の2,112億米ドルから2029年末までに4,282億米ドルに達すると予測されます。世界の治療用抗体市場の有利な成長要素は、慢性疾患の有病率の増加、バイオテクノロジーの進歩、個別化医療に向けた将来性によって推進されています。2024年～2029年の予測期間に、世界の治療用抗体はCAGRで11.2%の拡大が予測されます。バイオプロセスと製造技術の進歩は現在も続いています。これらの改良は、効率性の向上、コストの削減、より持続可能な治療用抗体の生産につながります。

世界保健機関（WHO）によると、非感染性疾患（NCDs）により毎年4,100万人が死亡しており、これは世界全体の死亡者数の74％に相当します。がん、自己免疫疾患、炎症性疾患を含む慢性疾患の罹患率の増加は、治療用抗体市場の主な促進要因です。抗体は、これらの疾病に関与する特定の分子を標的として設計することができ、標的を絞った効果的な治療を提供することができます。

COVID-19パンデミックは、感染症管理における治療用抗体の重要性を浮き彫りにしました。抗体が開発され、COVID-19の応急の治療薬として認可されたことは、世界の健康課題への対応における抗体の将来性を浮き彫りにしています。パンデミック中に効果的な治療法が緊急に必要とされたため、開発、臨床試験、薬事承認プロセスが迅速に行われました。このことは、新たな健康危機に対応する産業と規制当局の俊敏性を実証しています。

がんは世界的に主要死因であり、2020年に約1,000万人、つまり死亡者の約6人に1人ががんで死亡しています。精密医療の進歩とがんバイオマーカーの発見は、個別化された抗体療法の発展に寄与しています。特定の分子標的を特定することで、個々の患者や特定のがんのサブタイプに合わせた抗体の設計が可能になります。

研究者たちは、標的抗原に対する特異性と親和性を向上させた抗体の設計を続けています。これにより、副作用の少ない、より効果的で正確な治療介入が可能になります。ナノ抗体、二重特異性抗体、多重特異性抗体などの新しい抗体のフォーマットの開発により、治療能力と用途が拡大します。

世界の治療用抗体市場におけるヒト化由来の利用は、安全性と有効性の向上から標的ポートフォリオの拡大、先進のエンジニアリングアプローチの実現までに及ぶさまざまな機会を提供します。これらの機会は、抗体ベースの治療法の継続的な成長と多様化に寄与しています。抗体エンジニアリングの進歩により、治療特性の向上に向けた抗体構造の改変が可能になりました。この技術には、免疫原性を低減するためのヒト化、標的抗原への結合を強化するための親和性成熟、エフェクター機能の最適化に向けたアイソタイプスイッチングなどが含まれます。

当レポートでは、世界の治療用抗体市場について調査し、市場規模と予測、地域とセグメントの分析、主要動向と機会などの情報を提供しています。

目次

第1章 市場の背景

• 範囲と製品の見通し
• エグゼクティブサマリー
• 調査手法

第2章 戦略的推奨事項

第3章 世界の治療用抗体市場：実績と予測（2019年～2029年）

• 世界の治療用抗体市場に対するマクロ経済要因の影響の分析
• パイプラインのシナリオ
• 疫学：世界の慢性疾患の有病率
• 疫学：世界の慢性疾患の罹患率
• 世界の治療用抗体市場：市場規模とCAGR（2019年～2029年）
• 治療用抗体市場に対するCOVID-19の影響度
• 世界の治療用抗体市場セグメンテーション：製品タイプ別
  • 世界の治療用抗体市場：製品タイプ別、概要
  • 世界の治療用抗体の市場規模：モノクローナル抗体（金額）（2019年～2029年）
  • 世界の治療用抗体の市場規模：二重特異性抗体（金額）（2019年～2029年）
  • 世界の治療用抗体の市場規模：抗体薬物複合体（金額）（2019年～2029年）
  • 世界の治療用抗体の市場規模：その他（金額）（2019年～2029年）
• 世界の治療用抗体市場セグメンテーション：由来別
  • 世界の治療用抗体市場：由来別、概要
  • 世界の治療用抗体の市場規模：完全ヒト（金額）（2019年～2029年）
  • 世界の治療用抗体の市場規模：ヒト化（金額）（2019年～2029年）
  • 世界の治療用抗体の市場規模：その他（金額）（2019年～2029年）
• 世界の治療用抗体市場セグメンテーション：用途別
  • 世界の治療用抗体市場：用途別、概要
  • 世界の治療用抗体の市場規模：腫瘍（金額）（2019年～2029年）
  • 世界の治療用抗体の市場規模：自己免疫（金額）（2019年～2029年）
  • 世界の治療用抗体の市場規模：感染症（金額）（2019年～2029年）
  • 世界の治療用抗体の市場規模：その他（金額）（2019年～2029年）

第4章 世界の治療用抗体市場、地域分析

• 研究の地域範囲
• 地域のスナップショット

第5章 南北アメリカの治療用抗体市場：実績と予測（2019年～2029年）

• 南北アメリカの治療用抗体市場：スナップショット
• 南北アメリカの治療用抗体市場：市場規模とCAGR（2019年～2029年）
• 南北アメリカの治療用抗体市場：主な要因
• 南北アメリカの治療用抗体市場：セグメント分析
• 南北アメリカの治療用抗体市場セグメンテーション：製品タイプ別
• 南北アメリカの治療用抗体市場セグメンテーション：由来別
• 南北アメリカの治療用抗体市場セグメンテーション：用途別
• 南北アメリカの治療用抗体市場セグメンテーション：国別
  • 南北アメリカの治療用抗体市場：国別、概要
  • 米国の治療用抗体市場：市場規模とCAGR（2019年～2029年）
  • カナダの治療用抗体市場：市場規模とCAGR（2019年～2029年）
  • その他の南北アメリカの治療用抗体市場：市場規模とCAGR（2019年～2029年）

第6章 欧州の治療用抗体市場：実績と予測（2019年～2029年）

• 欧州の治療用抗体市場：スナップショット
• 欧州の治療用抗体市場：市場規模とCAGR（2019年～2029年）
• 欧州の治療用抗体市場：主な要因
• 欧州の治療用抗体市場：セグメント分析
• 欧州の治療用抗体市場セグメンテーション：製品タイプ別
• 欧州の治療用抗体市場セグメンテーション：由来別
• 欧州の治療用抗体市場セグメンテーション：用途別
• 欧州の治療用抗体市場セグメンテーション：国別
  • 欧州の治療用抗体市場：国別、概要
  • 英国の治療用抗体市場：市場規模とCAGR（2019年～2029年）
  • ドイツの治療用抗体市場：市場規模とCAGR（2019年～2029年）
  • フランスの治療用抗体市場：市場規模とCAGR（2019年～2029年）
  • スペインの治療用抗体市場：市場規模とCAGR（2019年～2029年）
  • その他の欧州の治療用抗体市場：市場規模とCAGR（2019年～2029年）

第7章 アジア太平洋の治療用抗体市場：実績と予測（2019年～2029年）

• アジア太平洋の治療用抗体市場：スナップショット
• アジア太平洋の治療用抗体市場：市場規模とCAGR（2019年～2029年）
• アジア太平洋の治療用抗体市場：主な要因
• アジア太平洋の治療用抗体市場：セグメント分析
• アジア太平洋の治療用抗体市場セグメンテーション：製品タイプ別
• アジア太平洋の治療用抗体市場セグメンテーション：由来別
• アジア太平洋の治療用抗体市場セグメンテーション：用途別
• アジア太平洋の治療用抗体市場セグメンテーション：国別
  • アジア太平洋の治療用抗体市場：国別、概要
  • 中国の治療用抗体市場：市場規模とCAGR（2019年～2029年）
  • 日本の治療用抗体市場：市場規模とCAGR（2019年～2029年）
  • 韓国の治療用抗体市場：市場規模とCAGR（2019年～2029年）
  • インドの治療用抗体市場：市場規模とCAGR（2019年～2029年）
  • その他のアジア太平洋の治療用抗体市場：市場規模とCAGR（2019年～2029年）

第8章 中東・アフリカの治療用抗体市場：実績と予測（2019年～2029年）

• 中東・アフリカの治療用抗体市場：スナップショット
• 中東・アフリカの治療用抗体市場：市場規模とCAGR（2019年～2029年）
• 中東・アフリカの治療用抗体市場：主な要因
• 中東・アフリカの治療用抗体市場：セグメント分析
• 中東・アフリカの治療用抗体市場セグメンテーション：製品タイプ別
• 中東・アフリカの治療用抗体市場セグメンテーション：由来別
• 中東・アフリカの治療用抗体市場セグメンテーション：用途別

第9章 市場力学

• 世界の治療用抗体市場に対する市場力学の影響の評価
• 促進要因
• 抑制要因
• 動向

第10章 産業エコシステム分析

• ポーター分析

第11章 競合ポジショニング

• 企業の製品ポジショニング
• 主要企業の市場シェア
• 企業プロファイル
  • F. Hoffmann-La Roche AG
  • Bristol-Myers Squibb Co.
  • AbbVie Inc.
  • Merck & Co., Inc.
  • Johnson & Johnson
  • Novartis
  • Regeneron Pharmaceuticals
  • Takeda Pharmaceuticals
  • Amgen, Inc.
  • Eli Lilly and Company

List of Figures

List of Figures

• Figure 1: Global Therapeutic Antibody Market Size, By Value, 2019-2022 (USD Billion)
• Figure 2: Global Therapeutic Antibody Market Size, By Value, 2023-2029 (USD Billion)
• Figure 3: Global Therapeutic Antibody Market Share, By Application, 2022 (%)
• Figure 4: Global Therapeutic Antibody Market Size, By Monoclonal antibody, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 5: Global Therapeutic Antibody Market Absolute Opportunity, By Monoclonal Antibody, 2019H-2029F (USD Billion)
• Figure 6: Global Therapeutic Antibody Market Size, By Bispecific antibody, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 7: Global Therapeutic Antibody Market Absolute Opportunity, By Bispecific antibody, 2019H-2029F (USD Billion)
• Figure 8: Global Therapeutic Antibody Market Size, By Antibody-drug conjugates, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 9: Global Therapeutic Antibody Market Absolute Opportunity, By Antibody-drug conjugates, 2019H-2029F (USD Billion)
• Figure 10: Global Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 11: Global Therapeutic Antibody Market Absolute Opportunity, By Others, 2019H-2029F (USD Billion)
• Figure 12: Global Therapeutic Antibody Market Size, By Fully Human, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 13: Global Therapeutic Antibody Market Absolute Opportunity, By Fully human, 2019H-2029F (USD Billion)
• Figure 14: Global Therapeutic Antibody Market Size, By Humanized, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 15: Global Therapeutic Antibody Market Absolute Opportunity, By Humanized, 2019H-2029F (USD Billion)
• Figure 16: Global Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 17: Global Therapeutic Antibody Market Absolute Opportunity, By Others, 2019H-2029F (USD Billion)
• Figure 18: Global Therapeutic Antibody Market Size, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 19: Global Therapeutic Antibody Market Absolute Opportunity, By Oncology, 2019H-2029F (USD Billion)
• Figure 20: Global Therapeutic Antibody Market Size, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 21: Global Therapeutic Antibody Market Absolute Opportunity, By Autoimmune, 2019H-2029F (USD Billion)
• Figure 22: Global Therapeutic Antibody Market Size, By Infectious disease, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 23: Global Therapeutic Antibody Market Absolute Opportunity, By Infectious Disease, 2019H-2029F (USD Billion)
• Figure 24: Global Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 25: Global Therapeutic Antibody Market Absolute Opportunity, By Others, 2019H-2029F (USD Billion)
• Figure 26: Americas Therapeutic Antibody Market Size, By Value, 2019H-2029F (USD Billion)
• Figure 27: Americas Therapeutic Antibody Market Share, By Application, 2022 (%)
• Figure 28: Americas Therapeutic Antibody Market, By Monoclonal antibody, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 29: Americas Therapeutic Antibody Market, By Bispecific antibody, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 30: Americas Therapeutic Antibody Market, By Antibody-drug conjugates, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 31: Americas Therapeutic Antibody Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 32: Americas Therapeutic Antibody Market, By Fully Human, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 33: Americas Therapeutic Antibody Market, By Humanized, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 34: Americas Therapeutic Antibody Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 35: Americas Therapeutic Antibody Market, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 36: Americas Therapeutic Antibody Market, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 37: Americas Therapeutic Antibody Market, By Infectious disease, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 38: Americas Therapeutic Antibody Marke, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 39: United States Therapeutic Antibody Market, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 40: United States Therapeutic Antibody Market Value, By Source, 2022 (USD Billion)
• Figure 41: United States Therapeutic Antibody Market Share, By Product Type, By Value, 2022 (%)
• Figure 42: United States Therapeutic Antibody Market Share, By Source, By Value, 2022 (%)
• Figure 43: United States Therapeutic Antibody Market Share, By Application, By Value, 2022 (%)
• Figure 44: Canada Therapeutic Antibody Market, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 45: Canada Therapeutic Antibody Market Value, By Source, 2022 (USD Billion)
• Figure 46: Canada Therapeutic Antibody Market Share, By Product Type, By Value, 2022 (%)
• Figure 47: Canada Therapeutic Antibody Market Share, By Source, By Value, 2022 (%)
• Figure 48: Canada Therapeutic Antibody Market Share, By Application, By Value, 2022 (%)
• Figure 49: Rest of Americas Therapeutic Antibody Market, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 50: Rest of Americas Therapeutic Antibody Market Value, By Source, 2022 (USD Billion)
• Figure 51: Rest of Americas Therapeutic Antibody Market Share, By Product Type, By Value, 2022 (%)
• Figure 52: Rest of Americas Therapeutic Antibody Market Share, By Source, By Value, 2022 (%)
• Figure 53: Rest of Americas Therapeutic Antibody Market Share, By Application, By Value, 2022 (%)
• Figure 54: Europe Therapeutic Antibody Market Size, By Value, 2019H-2029F (USD Billion)
• Figure 55: Europe Therapeutic Antibody Market Share, By Application, 2022 (%)
• Figure 56: Europe Therapeutic Antibody Market, By Monoclonal antibody, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 57: Europe Therapeutic Antibody Market, By Bispecific antibody, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 58: Europe Therapeutic Antibody Market, By Antibody-drug conjugates, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 59: Europe Therapeutic Antibody Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 60: Europe Therapeutic Antibody Market, By Fully Human, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 61: Europe Therapeutic Antibody Market, By Humanized, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 62: Europe Therapeutic Antibody Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 63: Europe Therapeutic Antibody Market, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 64: Europe Therapeutic Antibody Market, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 65: Europe Therapeutic Antibody Market, By Infectious disease, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 66: Europe Therapeutic Antibody Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 67: United Kingdom Therapeutic Antibody Market, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 68: United Kingdom Therapeutic Antibody Market Value, By Source, 2022 (USD Billion)
• Figure 69: United Kingdom Therapeutic Antibody Market Share, By Product Type, By Value, 2022 (%)
• Figure 70: United Kingdom Therapeutic Antibody Market Share, By Source, By Value, 2022 (%)
• Figure 71: United Kingdom Therapeutic Antibody Market Share, By Application, By Value, 2022 (%)
• Figure 72: Germany Therapeutic Antibody Market, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 73: Germany Therapeutic Antibody Market Value, By Source, 2022 (USD Billion)
• Figure 74: Germany Therapeutic Antibody Market Share, By Product Type, By Value, 2022 (%)
• Figure 75: Germany Therapeutic Antibody Market Share, By Source, By Value, 2022 (%)
• Figure 76: Germany Therapeutic Antibody Market Share, By Application, By Value, 2022 (%)
• Figure 77: France Therapeutic Antibody Market, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 78: France Therapeutic Antibody Market Value, By Source, 2022 (USD Billion)
• Figure 79: France Therapeutic Antibody Market Share, By Product Type, By Value, 2022 (%)
• Figure 80: France Therapeutic Antibody Market Share, By Source, By Value, 2022 (%)
• Figure 81: France Therapeutic Antibody Market Share, By Application, By Value, 2022 (%)
• Figure 82: Spain Therapeutic Antibody Market, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 83: Spain Therapeutic Antibody Market Value, By Source, 2022 (USD Billion)
• Figure 84: Spain Therapeutic Antibody Market Share, By Product Type, By Value, 2022 (%)
• Figure 85: Spain Therapeutic Antibody Market Share, By Source, By Value, 2022 (%)
• Figure 86: Spain Therapeutic Antibody Market Share, By Application, By Value, 2022 (%)
• Figure 87: Rest of Europe Therapeutic Antibody Market, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 88: Rest of Europe Therapeutic Antibody Market Value, By Source, 2022 (USD Billion)
• Figure 89: Rest of Europe Therapeutic Antibody Market Share, By Product Type, By Value, 2022 (%)
• Figure 90: Rest of Europe Therapeutic Antibody Market Share, By Source, By Value, 2022 (%)
• Figure 91: Rest of Europe Therapeutic Antibody Market Share, By Application, By Value, 2022 (%)
• Figure 92: Asia-Pacific Therapeutic Antibody Market Size, By Value, 2019H-2029F (USD Billion)
• Figure 93: Asia-Pacific Therapeutic Antibody Market Share, By Application, 2022 (%)
• Figure 94: Asia-Pacific Therapeutic Antibody Market, By Monoclonal antibody, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 95: Asia-Pacific Therapeutic Antibody Market, By Bispecific antibody, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 96: Asia-Pacific Therapeutic Antibody Market, By Antibody-drug conjugates, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 97: Asia-Pacific Therapeutic Antibody Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 98: Asia-Pacific Therapeutic Antibody Market, By Fully Human, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 99: Asia-Pacific Therapeutic Antibody Market, By Humanized, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 100: Asia-Pacific Therapeutic Antibody Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 101: Asia-Pacific Therapeutic Antibody Market, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 102: Asia-Pacific Therapeutic Antibody Market, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 103: Asia-Pacific Therapeutic Antibody Market, By Infectious disease, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 104: Asia-Pacific Therapeutic Antibody Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 105: China Therapeutic Antibody Market, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 106: China Therapeutic Antibody Market Value, By Source, 2022 (USD Billion)
• Figure 107: China Therapeutic Antibody Market Share, By Product Type, By Value, 2022 (%)
• Figure 108: China Therapeutic Antibody Market Share, By Source, By Value, 2022 (%)
• Figure 109: China Therapeutic Antibody Market Share, By Application, By Value, 2022 (%)
• Figure 110: Japan Therapeutic Antibody Market, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 111: Japan Therapeutic Antibody Market Value, By Source, 2022 (USD Billion)
• Figure 112: Japan Therapeutic Antibody Market Share, By Product Type, By Value, 2022 (%)
• Figure 113: Japan Therapeutic Antibody Market Share, By Source, By Value, 2022 (%)
• Figure 114: Japan Therapeutic Antibody Market Share, By Application, By Value, 2022 (%)
• Figure 115: South Korea Therapeutic Antibody Market, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 116: South Korea Therapeutic Antibody Market Value, By Source, 2022 (USD Billion)
• Figure 117: South Korea Therapeutic Antibody Market Share, By Product Type, By Value, 2022 (%)
• Figure 118: South Korea Therapeutic Antibody Market Share, By Source, By Value, 2022 (%)
• Figure 119: South Korea Therapeutic Antibody Market Share, By Application, By Value, 2022 (%)
• Figure 120: India Therapeutic Antibody Market, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 121: India Therapeutic Antibody Market Value, By Source, 2022 (USD Billion)
• Figure 122: India Therapeutic Antibody Market Share, By Product Type, By Value, 2022 (%)
• Figure 123: India Therapeutic Antibody Market Share, By Source, By Value, 2022 (%)
• Figure 124: India Therapeutic Antibody Market Share, By Application, By Value, 2022 (%)
• Figure 125: Rest of Asia-Pacific Therapeutic Antibody Market, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 126: Rest of Asia-Pacific Therapeutic Antibody Market Value, By Source, 2022 (USD Billion)
• Figure 127: Rest of Asia-Pacific Therapeutic Antibody Market Share, By Product Type, By Value, 2022 (%)
• Figure 128: Rest of Asia-Pacific Therapeutic Antibody Market Share, By Source, By Value, 2022 (%)
• Figure 129: Rest of Asia-Pacific Therapeutic Antibody Market Share, By Application, By Value, 2022 (%)
• Figure 130: Middle East and Africa Therapeutic Antibody Market Size, By Value, 2019H-2029F (USD Billion)
• Figure 131: Middle East and Africa Therapeutic Antibody Market Share, By Application, 2022 (%)
• Figure 132: Middle East and Africa Therapeutic Antibody Market, By Monoclonal antibody, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 133: Middle East and Africa Therapeutic Antibody Market, By Bispecific antibody, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 134: Middle East and Africa Therapeutic Antibody Market, By Antibody drug conjugates, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 135: Middle East and Africa Therapeutic Antibody Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 136: Middle East and Africa Therapeutic Antibody Market, By Fully human, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 137: Middle East and Africa Therapeutic Antibody Market, By Humanized, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 138: Middle East and Africa Therapeutic Antibody Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 139: Middle East and Africa Therapeutic Antibody Market, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 140: Middle East and Africa Therapeutic Antibody Market, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 141: Middle East and Africa Therapeutic Antibody Market, By Infectious disease, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 142: Middle East and Africa Therapeutic Antibody Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• Figure 143: Global Impact of Drivers and Restraints
• Figure 144: Market Share of Prominent Companies of Therapeutic Antibody, 2022 (%)
• Figure 145: Roche Revenues, 2020-2022 (USD Million)
• Figure 146: Roche Revenue , By Business Segment, 2022 (%)
• Figure 147: Bristol-Myers Squibb Revenues, 2020-2022 (USD Million)
• Figure 148: Bristol-Myers Squibb Revenues, By Geographic Segments, 2022 (%)
• Figure 149: AbbVie Inc. Revenue, 2020-2022 (USD Million)
• Figure 150: AbbVie Inc. Revenue, Product Sales by Product Segment, 2022 (%)
• Figure 151: AbbVie Inc. Revenue, By Geographical Segments, 2022 (%)
• Figure 152: Merck & Co., Inc. Revenues, 2020-2022 (USD Million)
• Figure 153: Merck & Co., Inc. Revenues, By Geographic Segments, 2022 (%)
• Figure 154: Merck & Co., Inc. Revenue, By Business Segments, 2022 (%)
• Figure 155: Johnson & Johnson Revenues, 2020-2022 (USD Million)
• Figure 156: Johnson & Johnson Revenues, By Geographic Segments, 2022 (%)
• Figure 157: Johnson & Johnson Revenue , By Business Segments, 2022 (%)
• Figure 158: Novartis Revenue, 2020-2022 (USD Million)
• Figure 159: Novartis Revenue, By Business Segments, 2022 (%)
• Figure 160: Novartis Revenue, By Geographical Segments, 2022 (%)
• Figure 161: Regeneron Revenue, 2020-2022 (USD Billion)
• Figure 162: Regeneron Revenue, By Business Segments, 2022 (%)
• Figure 163: Regeneron Revenue, By Geographical Segments, 2022 (%)
• Figure 164: Takeda Pharmaceuticals Revenues, 2019-2021 (USD Million)
• Figure 165: Takeda Pharmaceuticals Revenues, By Geographic Segments, 2021 (%)
• Figure 166: Amgen, Inc. Revenues, 2020-2022 (USD Million)
• Figure 167: Amgen, Inc. Revenues, By Geographic Segments, 2022 (%)
• Figure 168: Amgen, Inc. Revenue , By Products, 2022 (%)
• Figure 169: Eli Lilly and Company Revenue, 2020-2022 (USD Million)
• Figure 170: Eli Lilly and Company Revenue, By Geographic Segments, 2022 (%)
• Figure 171: Eli Lilly and Company Revenue, By Therapeutic Area, 2022 (%)

List of Tables

Table A1: Global Impact of Macro Economic Factors, By Region

Table A2: Therapeutic Antibody in Pipeline

Table A3: United States Therapeutic Antibody Market, By Product Type, By Value, 2019-2022 (USD Billion)

Table A4: United States Therapeutic Antibody Market, By Product Type, By Value, 2023-2029 (USD Billion)

Table A5: United States Therapeutic Antibody Market, By Source, By Value, 2019-2022 (USD Billion)

Table A6: United States Therapeutic Antibody Market, By Source, By Value, 2023-2029 (USD Billion)

Table A7: United States Therapeutic Antibody Market, By Application, By Value, 2019-2022 (USD Billion)

Table A8: United States Therapeutic Antibody Market, By Application, By Value, 2023-2029 (USD Billion)

Table A9: Canada Therapeutic Antibody Market, By Product Type, By Value, 2019-2022 (USD Billion)

Table A10: Canada Therapeutic Antibody Market, By Product Type, By Value, 2023-2029 (USD Billion)

Table A11: Canada Therapeutic Antibody Market, By Source, By Value, 2019-2022 (USD Billion)

Table A12: Canada Therapeutic Antibody Market, By Source, By Value, 2023-2029 (USD Billion)

Table A13: Canada Therapeutic Antibody Market, By Application, By Value, 2019-2022 (USD Billion)

Table A14: Canada Therapeutic Antibody Market, By Application, By Value, 2023-2029 (USD Billion)

Table A15: Rest of Americas Therapeutic Antibody Market, By Product Type, By Value, 2019-2022 (USD Billion)

Table A16: Rest of Americas Therapeutic Antibody Market, By Product Type, By Value, 2023-2029 (USD Billion)

Table A17: Rest of Americas Therapeutic Antibody Market, By Source, By Value, 2019-2022 (USD Billion)

Table A18: Rest of Americas Therapeutic Antibody Market, By Source, By Value, 2023-2029 (USD Billion)

Table A19: Rest of Americas Therapeutic Antibody Market, By Application, By Value, 2019-2022 (USD Billion)

Table A20: Rest of Americas Therapeutic Antibody Market, By Application, By Value, 2023-2029 (USD Billion)

Table A21: United Kingdom Therapeutic Antibody Market, By Product Type, By Value, 2019-2022 (USD Billion)

Table A22: United Kingdom Therapeutic Antibody Market, By Product Type, By Value, 2023-2029 (USD Billion)

Table A23: United Kingdom Therapeutic Antibody Market, By Source, By Value, 2019-2022 (USD Billion)

Table A24: United Kingdom Therapeutic Antibody Market, By Source, By Value, 2023-2029 (USD Billion)

Table A25: United Kingdom Therapeutic Antibody Market, By Application, By Value, 2019-2022 (USD Billion)

Table A26: United Kingdom Therapeutic Antibody Market, By Application, By Value, 2023-2029 (USD Billion)

Table A27: Germany Therapeutic Antibody Market, By Product Type, By Value, 2019-2022 (USD Billion)

Table A28: Germany Therapeutic Antibody Market, By Product Type, By Value, 2023-2029 (USD Billion)

Table A29: Germany Therapeutic Antibody Market, By Source, By Value, 2019-2022 (USD Billion)

Table A30: Germany Therapeutic Antibody Market, By Source, By Value, 2023-2029 (USD Billion)

Table A31: Germany Therapeutic Antibody Market, By Application, By Value, 2019-2022 (USD Billion)

Table A32: Germany Therapeutic Antibody Market, By Application, By Value, 2023-2029 (USD Billion)

Table A33: France Therapeutic Antibody Market, By Product Type, By Value, 2019-2022 (USD Billion)

Table A34: France Therapeutic Antibody Market, By Product Type, By Value, 2023-2029 (USD Billion)

Table A35: France Therapeutic Antibody Market, By Source, By Value, 2019-2022 (USD Billion)

Table A36: France Therapeutic Antibody Market, By Source, By Value, 2023-2029 (USD Billion)

Table A37: France Therapeutic Antibody Market, By Application, By Value, 2019-2022 (USD Billion)

Table A38: France Therapeutic Antibody Market, By Application, By Value, 2023-2029 (USD Billion)

Table A39: Spain Therapeutic Antibody Market, By Product Type, By Value, 2019-2022 (USD Billion)

Table A40: Spain Therapeutic Antibody Market, By Product Type, By Value, 2023-2029 (USD Billion)

Table A41: Spain Therapeutic Antibody Market, By Source, By Value, 2019-2022 (USD Billion)

Table A42: Spain Therapeutic Antibody Market, By Source, By Value, 2023-2029 (USD Billion)

Table A43: Spain Therapeutic Antibody Market, By Application, By Value, 2019-2022 (USD Billion)

Table A44: Spain Therapeutic Antibody Market, By Application, By Value, 2023-2029 (USD Billion)

Table A45: Rest of Europe Therapeutic Antibody Market, By Product Type, By Value, 2019-2022 (USD Billion)

Table A46: Rest of Europe Therapeutic Antibody Market, By Product Type, By Value, 2023-2029 (USD Billion)

Table A47: Rest of Europe Therapeutic Antibody Market, By Source, By Value, 2019-2022 (USD Billion)

Table A48: Rest of Europe Therapeutic Antibody Market, By Source, By Value, 2023-2029 (USD Billion)

Table A49: Rest of Europe Therapeutic Antibody Market, By Application, By Value, 2019-2022 (USD Billion)

Table A50: Rest of Europe Therapeutic Antibody Market, By Application, By Value, 2023-2029 (USD Billion)

Table A51: China Therapeutic Antibody Market, By Product Type, By Value, 2019-2022 (USD Billion)

Table A52: China Therapeutic Antibody Market, By Product Type, By Value, 2023-2029 (USD Billion)

Table A53: China Therapeutic Antibody Market, By Source, By Value, 2019-2022 (USD Billion)

Table A54: China Therapeutic Antibody Market, By Source, By Value, 2023-2029 (USD Billion)

Table A55: China Therapeutic Antibody Market, By Application, By Value, 2019-2022 (USD Billion)

Table A56: China Therapeutic Antibody Market, By Application, By Value, 2023-2029 (USD Billion)

Table A57: Japan Therapeutic Antibody Market, By Product Type, By Value, 2019-2022 (USD Billion)

Table A58: Japan Therapeutic Antibody Market, By Product Type, By Value, 2023-2029 (USD Billion)

Table A59: Japan Therapeutic Antibody Market, By Source, By Value, 2019-2022 (USD Billion)

Table A60: Japan Therapeutic Antibody Market, By Source, By Value, 2023-2029 (USD Billion)

Table A61: Japan Therapeutic Antibody Market, By Application, By Value, 2019-2022 (USD Billion)

Table A62: Japan Therapeutic Antibody Market, By Application, By Value, 2023-2029 (USD Billion)

Table A63: South Korea Therapeutic Antibody Market, By Product Type, By Value, 2019-2022 (USD Billion)

Table A64: South Korea Therapeutic Antibody Market, By Product Type, By Value, 2023-2029 (USD Billion)

Table A65: South Korea Therapeutic Antibody Market, By Source, By Value, 2019-2022 (USD Billion)

Table A66: South Korea Therapeutic Antibody Market, By Source, By Value, 2023-2029 (USD Billion)

Table A67: South Korea Therapeutic Antibody Market, By Application, By Value, 2019-2022 (USD Billion)

Table A68: South Korea Therapeutic Antibody Market, By Application, By Value, 2023-2029 (USD Billion)

Table A69: India Therapeutic Antibody Market, By Product Type, By Value, 2019-2022 (USD Billion)

Table A70: India Therapeutic Antibody Market, By Product Type, By Value, 2023-2029 (USD Billion)

Table A71: India Therapeutic Antibody Market, By Source, By Value, 2019-2022 (USD Billion)

Table A72: India Therapeutic Antibody Market, By Source, By Value, 2023-2029 (USD Billion)

Table A73: India Therapeutic Antibody Market, By Application, By Value, 2019-2022 (USD Billion)

Table A74: India Therapeutic Antibody Market, By Application, By Value, 2023-2029 (USD Billion)

Table A75: Rest of Asia-Pacific Therapeutic Antibody Market, By Product Type Industry, By Value, 2019-2022 (USD Billion)

Table A76: Rest of Asia-Pacific Therapeutic Antibody Market, By Product Type Industry, By Value, 2023-2029 (USD Billion)

Table A77: Rest of Asia-Pacific Therapeutic Antibody Market, By Source, By Value, 2019-2022 (USD Billion)

Table A78: Rest of Asia-Pacific Therapeutic Antibody Market, By Source, By Value, 2023-2029 (USD Billion)

Table A79: Rest of Asia-Pacific Therapeutic Antibody Market, By Application, By Value, 2019-2022 (USD Billion)

Table A80: Rest of Asia-Pacific Therapeutic Antibody Market, By Application, By Value, 2023-2029 (USD Billion)

Table A81: Roche Key Financials, 2020-2022

Table A82: Bristol-Myers Squibb Key Financials, 2020-2022

Table A83: AbbVie Inc. Key Company Financials, 2020-2022

Table A84: Merck & Co., Inc. Key Financials, 2020-2022

Table A85: Johnson & Johnson Key Financials, 2020-2022

Table A86: Novartis Key Company Financials, 2020-2022

Table A87: Regeneron Key Company Financials, 2020-2022

Table A88: Takeda Pharmaceuticals Key Financials, 2020-2022

Table A89: Amgen, Inc. Key Financials, 2020-2022

Table A90: Eli Lilly and Company Key Financials, 2020-2022

Executive Summary

Azoth Analytics has released a research report titled "Global Therapeutic Antibody Market (2023 Edition)" which provides a complete analysis of the Global Therapeutic Antibody industry in terms of market segmentation By Product Type (Monoclonal Antibody, Bispecific Antibody, Antibody Drug Conjugates, Others), By Source (Fully Human, Humanized, Others), By Application (Oncology, Autoimmune, Infectious disease, Others), By Region and by Country for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, United Kingdom, Germany, France, Spain, China, Japan, South Korea, India). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.

The research report also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market evolution.

The Global Therapeutic Antibody Market is expected to generate USD 428.20 billion by the end of 2029, up from USD 211.2 billion in 2022. A favourable growth element for the global Therapeutic Antibody market is propelled by the increasing prevalence of chronic diseases, advancements in biotechnology, and the potential for personalized medicine. During the forecast period, 2024-2029, Global Therapeutic Antibody is expected to expand at a CAGR of 11.2%. Advances in bioprocessing and manufacturing technologies are ongoing. These improvements can lead to increased efficiency, reduced costs, and a more sustainable production of therapeutic antibodies.

According to the World Health Organization (WHO), Noncommunicable diseases (NCDs) kill 41 million people each year, equivalent to 74% of all deaths globally. The rising incidence of chronic diseases, including cancer, autoimmune disorders, and inflammatory conditions, is a major driver for the therapeutic antibody market. Antibodies can be designed to target specific molecules involved in these diseases, providing targeted and effective treatments.

The COVID-19 pandemic has underscored the importance of therapeutic antibodies in infectious disease management. Antibodies have been developed and authorized for emergency use in the treatment of COVID-19, highlighting their potential in addressing global health challenges. The urgent need for effective treatments during the pandemic has led to expedited development, clinical trials, and regulatory approval processes. This has demonstrated the agility of the industry and regulatory agencies in responding to emerging health crises.

Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. Advances in precision medicine and the discovery of cancer biomarkers contribute to the development of personalized antibody therapies. Identifying specific molecular targets allows for the design of antibodies tailored to individual patients or specific cancer subtypes.

Researchers continue to engineer antibodies with improved specificity and affinity for their target antigens. This can lead to more effective and precise therapeutic interventions with fewer side effects. Development of novel antibody formats, such as nanobodies, bispecific antibodies, and multispecific antibodies, to expand the therapeutic capabilities and applications.

The utilization of humanized sources in the global therapeutic antibody market offers a range of opportunities, from improving safety and efficacy to expanding target portfolios and enabling advanced engineering approaches. These opportunities contribute to the continued growth and diversification of antibody-based therapies. Advances in antibody engineering have allowed the modification of antibody structures for improved therapeutic properties. Techniques include humanization to reduce immunogenicity, affinity maturation for enhanced binding to target antigens, and isotype switching for optimized effector functions.

Scope of the Report

• The report analyses the Therapeutic Antibody Market by Value (USD Billion).
• The report presents the analysis of the Therapeutic Antibody Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
• The report analyses the Therapeutic Antibody Market by Product Type (Monoclonal antibody, Bispecific antibody, Antibody-drug conjugates, Others).
• The report analyses the Therapeutic Antibody Market by Source (Fully human, Humanized, Others).
• The report analyses the Therapeutic Antibody Market by Application (Oncology, Autoimmune, Infectious disease, Others).
• The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by services, by mode of operation & by end users.
• Also, the major opportunities, trends, drivers and challenges of the industry have been analysed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include F. Hoffmann-La Roche AG, Bristol-Myers Squibb Co., AbbVie Inc., Merck & Co., Inc., Johnson & Johnson, Novartis, Regeneron Pharmaceuticals, Takeda Pharmaceuticals, Amgen, Inc., Eli Lilly and Company.

Table of Contents

1. Market Background

• 1.1 Scope and Product Outlook
• 1.2 Executive Summary
• 1.3 Research Methodology

2. Strategic Recommendations

3. Global Therapeutic Antibody Market: Historic and Forecast (2019-2029)

• 3.1 Impact Analysis of Macro Economic Factors on the Global Therapeutic Antibody Market
• 3.2 Pipeline Scenario
• 3.3 Epidemiology: Global Chronic Disease Prevalence
• 3.4 Epidemiology: Global Chronic Disease Incidence
• 3.5 Global Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
• 3.6 Degree of Impact of Covid-19 on Therapeutic Antibody Market
• 3.7 Global Therapeutic Antibody Market Segmentation: By Product Type
  • 3.7.1 Global Therapeutic Antibody Market, By Product Type Overview
  • 3.7.2 Global Therapeutic Antibody Market Size, By Monoclonal Antibody, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.7.3 Global Therapeutic Antibody Market Size, By Bispecific Antibody, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.7.4 Global Therapeutic Antibody Market Size, By Antibody-drug conjugates, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.7.5 Global Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 3.8 Global Therapeutic Antibody Market Segmentation: By Source
  • 3.8.1 Global Therapeutic Antibody Market, By Source Overview
  • 3.8.2 Global Therapeutic Antibody Market Size, By Fully Human, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.8.3 Global Therapeutic Antibody Market Size, By Humanized, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.8.4 Global Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 3.9 Global Therapeutic Antibody Market Segmentation: By Application
  • 3.9.1 Global Therapeutic Antibody Market, By Application Overview
  • 3.9.2 Global Therapeutic Antibody Market Size, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.9.3 Global Therapeutic Antibody Market Size, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.9.4 Global Therapeutic Antibody Market Size, By Infectious Disease, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.9.5 Global Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

4. Global Therapeutic Antibody Market, Regional Analysis

• 4.1 Regional Coverage of the Study
• 4.2 Regional Snapshot

5. Americas Therapeutic Antibody Market: Historic and Forecast (2019-2029)

• 5.1 Americas Therapeutic Antibody Market: Snapshot
• 5.2 Americas Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
• 5.3 Americas Therapeutic Antibody Market: Key Factors
• 5.4 Americas Therapeutic Antibody Market: Segment Analysis
• 5.5 Americas Therapeutic Antibody Market Segmentation: By Product Type
  • 5.5.1 Americas Therapeutic Antibody Market, By Product Type Overview
  • 5.5.2 Americas Therapeutic Antibody Market Size, By Monoclonal Antibody, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.5.3 Americas Therapeutic Antibody Market Size, By Bispecific Antibody, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.5.4 Americas Therapeutic Antibody Market Size, By Antibody-drug conjugates, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.5.5 Americas Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 5.6 Americas Therapeutic Antibody Market Segmentation: By Source
  • 5.6.1 Americas Therapeutic Antibody Market, By Source Overview
  • 5.6.2 Americas Therapeutic Antibody Market Size, By Fully Human, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.6.3 Americas Therapeutic Antibody Market Size, By Humanized, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.6.4 Americas Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 5.7 Americas Therapeutic Antibody Market Segmentation: By Application
  • 5.7.1 Americas Therapeutic Antibody Market, By Application Overview
  • 5.2.2 Americas Therapeutic Antibody Market Size, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.7.3 Americas Therapeutic Antibody Market Size, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.7.4 Americas Therapeutic Antibody Market Size, By Infectious Disease, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.7.5 Americas Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 5.8 Americas Therapeutic Antibody Market Segmentation: By Country
  • 5.8.1 Americas Therapeutic Antibody Market, By Country Overview
  • 5.8.2 United States Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 5.8.2.1 United States Therapeutic Antibody Market, By Product Type
    • 5.8.2.2 United States Therapeutic Antibody Market, By Source
    • 5.8.2.3 United States Therapeutic Antibody Market, By Application
  • 5.8.3 Canada Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 5.8.3.1 Canada Therapeutic Antibody Market, By Product Type
    • 5.8.3.2 Canada Therapeutic Antibody Market, By Source
    • 5.8.3.3 Canada Therapeutic Antibody Market, By Application
  • 5.10.4 Rest of Americas Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 5.10.4.1 Rest of Americas Therapeutic Antibody Market, By Product Type
    • 5.10.4.2 Rest of Americas Therapeutic Antibody Market, By Source
    • 5.10.4.3 Rest of Americas Therapeutic Antibody Market, By Application

6. Europe Therapeutic Antibody Market: Historic and Forecast (2019-2029)

• 6.1 Europe Therapeutic Antibody Market: Snapshot
• 6.2 Europe Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
• 6.3 Europe Therapeutic Antibody Market: Key Factors
• 6.4 Europe Therapeutic Antibody Market: Segment Analysis
• 6.5 Europe Therapeutic Antibody Market Segmentation: By Product Type
  • 6.5.1 Europe Therapeutic Antibody Market, By Product Type Overview
  • 6.5.2 Europe Therapeutic Antibody Market Size, By Monoclonal antibody, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.5.3 Europe Therapeutic Antibody Market Size, By Bispecific antibody, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.5.4 Europe Therapeutic Antibody Market Size, By Antibody drug conjugates, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.7.5 Europe Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 6.6 Europe Therapeutic Antibody Market Segmentation: By Source
  • 6.6.1 Europe Therapeutic Antibody Market, By Source Overview
  • 6.6.2 Europe Therapeutic Antibody Market Size, By Fully Human, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.6.3 Europe Therapeutic Antibody Market Size, By Humanized, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.6.4 Europe Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 6.7 Europe Therapeutic Antibody Market Segmentation: By Application
  • 6.7.1 Europe Therapeutic Antibody Market, By Application Overview
  • 6.5.2 Europe Therapeutic Antibody Market Size, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.5.3 Europe Therapeutic Antibody Market Size, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.5.4 Europe Therapeutic Antibody Market Size, By Infectious Disease, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.7.5 Europe Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 6.8 Europe Therapeutic Antibody Market Segmentation: By Country
  • 6.8.1 Europe Therapeutic Antibody Market, By Country Overview
  • 6.8.2 United Kingdom Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 6.8.2.1 United Kingdom Therapeutic Antibody Market, By Product Type
    • 6.8.2.2 United Kingdom Therapeutic Antibody Market, By Source
    • 6.8.2.3 United Kingdom Therapeutic Antibody Market, By Application
  • 6.8.3 Germany Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 6.8.3.1 Germany Therapeutic Antibody Market, By Product Type
    • 6.8.3.2 Germany Therapeutic Antibody Market, By Source
    • 6.8.3.3 Germany Therapeutic Antibody Market, By Application
  • 6.8.4 France Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 6.8.4.1 France Therapeutic Antibody Market, By Product Type
    • 6.8.4.2 France Therapeutic Antibody Market, By Source
    • 6.8.4.3 France Therapeutic Antibody Market, By Application
  • 6.8.5 Spain Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 6.8.5.1 Spain Therapeutic Antibody Market, By Product Type
    • 6.8.5.2 Spain Therapeutic Antibody Market, By Source
    • 6.8.5.3 Spain Therapeutic Antibody Market, By Application
  • 6.8.7 Rest of Europe Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 6.8.6.1 Rest of Europe Therapeutic Antibody Market, By Product Type
    • 6.8.6.2 Rest of Europe Therapeutic Antibody Market, By Source
    • 6.8.6.3 Rest of Europe Therapeutic Antibody Market, By Application

7. Asia Pacific Therapeutic Antibody Market: Historic and Forecast (2019-2029)

• 7.1 Asia Pacific Therapeutic Antibody Market: Snapshot
• 7.2 Asia Pacific Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
• 7.3 Asia Pacific Therapeutic Antibody Market: Key Factors
• 7.4 Asia Pacific Therapeutic Antibody Market: Segment Analysis
• 7.5 Asia Pacific Therapeutic Antibody Market Segmentation: By Product Type
  • 7.5.1 Asia Pacific Therapeutic Antibody Market, By Product Type Overview
  • 7.5.2 Asia Pacific Therapeutic Antibody Market Size, By Monoclonal antibody, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.5.3 Asia Pacific Therapeutic Antibody Market Size, By Bispecific antibody, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.5.4 Asia Pacific Therapeutic Antibody Market Size, By Antibody-drug conjugates, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.7.5 Asia Pacific Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 7.6 Asia Pacific Therapeutic Antibody Market Segmentation: By Source
  • 7.6.1 Asia Pacific Therapeutic Antibody Market, By Source Overview
  • 7.6.2 Asia Pacific Therapeutic Antibody Market Size, By Fully Human, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.6.3 Asia Pacific Therapeutic Antibody Market Size, By Humanized, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.6.4 Asia Pacific Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 7.7 Asia Pacific Therapeutic Antibody Market Segmentation: By Application
  • 7.7.1 Asia Pacific Therapeutic Antibody Market, By ApplicationOverview
  • 7.7.2 Asia Pacific Therapeutic Antibody Market Size, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.7.3 Asia Pacific Therapeutic Antibody Market Size, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.5.4 Asia Pacific Therapeutic Antibody Market Size, By Infectious Disease, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.7.5 Asia Pacific Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 7.8 Asia Pacific Therapeutic Antibody Market Segmentation: By Country
  • 7.8.1 Asia Pacific Therapeutic Antibody Market, By Country Overview
  • 7.8.2 China Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 7.8.2.1 China Therapeutic Antibody Market, By Product Type
    • 7.8.2.2 China Therapeutic Antibody Market, By Source
    • 7.8.2.3 China Therapeutic Antibody Market, By Application
  • 7.8.3 Japan Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 7.8.3.1 Japan Therapeutic Antibody Market, By Product Type
    • 7.8.3.2 Japan Therapeutic Antibody Market, By Source
    • 7.8.3.3 Japan Therapeutic Antibody Market, By Application
  • 7.8.4 South Korea Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 7.8.4.1 South Korea Therapeutic Antibody Market, By Product Type
    • 7.8.4.2 South Korea Therapeutic Antibody Market, By Source
    • 7.8.4.3 South Korea Therapeutic Antibody Market, By Application
  • 7.8.5 India Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 7.8.5.1 India Therapeutic Antibody Market, By Product Type
    • 7.8.5.2 India Therapeutic Antibody Market, By Source
    • 7.8.5.3 India Therapeutic Antibody Market, By Application
  • 7.8.6 Rest of Asia Pacific Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 7.8.6.1 Rest of Asia Pacific Therapeutic Antibody Market, By Product Type
    • 7.8.6.2 Rest of Asia Pacific Therapeutic Antibody Market, By Source
    • 7.8.6.3 Rest of Asia Pacific Therapeutic Antibody Market, By Application

8. Middle East and Africa Therapeutic Antibody Market: Historic and Forecast (2019-2029)

• 8.1 Middle East and Africa Therapeutic Antibody Market: Snapshot
• 8.2 Middle East and Africa Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
• 8.3 Middle East and Africa Therapeutic Antibody Market: Key Factors
• 8.4 Middle East and Africa Therapeutic Antibody Market: Segment Analysis
• 8.5 Middle East and Africa Therapeutic Antibody Market Segmentation: By Product Type
  • 8.5.1 Middle East and Africa Therapeutic Antibody Market, By Product Type Overview
  • 8.5.2 Middle East and Africa Therapeutic Antibody Market Size, By Monoclonal Antibody, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.5.3 Middle East and Africa Therapeutic Antibody Market, By Bispecific Antibody, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.5.4 Middle East and Africa Therapeutic Antibody Market Size, By Antibody-drug conjugates, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.7.5 Middle East and Africa Therapeutic Antibody Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 8.6 Middle East and Africa Therapeutic Antibody Market Segmentation: By Source
  • 8.6.1 Middle East and Africa Therapeutic Antibody Market, By Source Overview
  • 8.6.2 Middle East and Africa Therapeutic Antibody Market Size, By Fully Human, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.6.3 Middle East and Africa Therapeutic Antibody Market Size, By Humanized, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.6.4 Middle East and Africa Therapeutic Antibody Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 8.7 Middle East and Africa Therapeutic Antibody Market Segmentation: By Application
  • 8.7.1 Middle East and Africa Therapeutic Antibody Market, By Application Overview
  • 8.7.2 Middle East and Africa Therapeutic Antibody Market Size, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.7.3 Middle East and Africa Therapeutic Antibody Market Size, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.7.4 Middle East and Africa Therapeutic Antibody Market Size, By Infectious disease, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.7.5 Middle East and Africa Therapeutic Antibody Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

9. Market Dynamics

• 9.1 Impact Assessment of Market Dynamics on the Global Therapeutic Antibody Market
• 9.2 Drivers
• 9.3 Restraints
• 9.4 Trends

10. Industry Ecosystem Analysis

• 10.1 Porter Analysis

11. Competitive Positioning

• 11.1 Companies' Product Positioning
• 11.2 Market Share of Leading Companies
• 11.3 Company Profiling
  • 11.3.1 F. Hoffmann-La Roche AG
  • 11.3.2 Bristol-Myers Squibb Co.
  • 11.4.3 AbbVie Inc.
  • 11.3.4 Merck & Co., Inc.
  • 11.3.5 Johnson & Johnson
  • 11.3.6 Novartis
  • 11.3.7 Regeneron Pharmaceuticals
  • 11.3.8 Takeda Pharmaceuticals
  • 11.3.9 Amgen, Inc.
  • 11.3.10 Eli Lilly and Company